Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004589881> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2004589881 endingPage "195" @default.
- W2004589881 startingPage "184" @default.
- W2004589881 abstract "Summary The treatment of ST-segment elevation myocardial infarction (STEMI) has improved over the past decades, mainly due to reperfusion therapies. The aim of this article is to provide an updated review of adjunctive antithrombotic therapy to reperfusion strategies for STEMI. As compared to unfractionated heparin (UFH), among patients treated with thrombolysis, low-molecular- weight heparins (LMWHs),mainly enoxaparin, fonda-parinux and clopidogrel have been shown to improve outcome in terms of death and reinfarction, whereas GP IIb-IIIa inhibitors, mainly abciximab, and direct thrombin inhibitors have reduced reinfarction, but not mortality. Among patients undergoing primary angioplasty, early UFH should still be regarded as the gold standard in anticoagulation therapy. In addition to ASA, early GP IIb-IIIa inhibitors, especially abciximab, should be considered since it has been shown to provide further benefits in terms of preprocedural recanalization. Despite the positive results observed in the HORIZONS trial, additional studies are needed to investigate the role of bivalirudin as compared to abciximab administration. In our opinion, bivalirudin may be considered instead of GP IIb-IIIa inhibitors among STEMI patients at high risk for bleeding complications. Due to the very low mortality currently achieved by primary angioplasty, a further reduction in short- or medium-term mortality would be quite improbable to be observed. Thus, additional endpoints, such as infarct size and myocardial perfusion, may be considered in future randomized trials among patients undergoing mechanical revascularization for STEMI." @default.
- W2004589881 created "2016-06-24" @default.
- W2004589881 creator A5044500702 @default.
- W2004589881 creator A5064670948 @default.
- W2004589881 date "2008-01-01" @default.
- W2004589881 modified "2023-09-25" @default.
- W2004589881 title "Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction" @default.
- W2004589881 doi "https://doi.org/10.1160/th08-03-0174" @default.
- W2004589881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18690336" @default.
- W2004589881 hasPublicationYear "2008" @default.
- W2004589881 type Work @default.
- W2004589881 sameAs 2004589881 @default.
- W2004589881 citedByCount "17" @default.
- W2004589881 countsByYear W20045898812013 @default.
- W2004589881 countsByYear W20045898812015 @default.
- W2004589881 countsByYear W20045898812016 @default.
- W2004589881 countsByYear W20045898812017 @default.
- W2004589881 countsByYear W20045898812018 @default.
- W2004589881 crossrefType "journal-article" @default.
- W2004589881 hasAuthorship W2004589881A5044500702 @default.
- W2004589881 hasAuthorship W2004589881A5064670948 @default.
- W2004589881 hasConcept C126322002 @default.
- W2004589881 hasConcept C164705383 @default.
- W2004589881 hasConcept C2776336681 @default.
- W2004589881 hasConcept C2777015399 @default.
- W2004589881 hasConcept C2777292125 @default.
- W2004589881 hasConcept C2777557582 @default.
- W2004589881 hasConcept C2777565915 @default.
- W2004589881 hasConcept C2777849778 @default.
- W2004589881 hasConcept C2777871224 @default.
- W2004589881 hasConcept C2779464278 @default.
- W2004589881 hasConcept C2779581417 @default.
- W2004589881 hasConcept C2780326628 @default.
- W2004589881 hasConcept C2780387585 @default.
- W2004589881 hasConcept C2780400711 @default.
- W2004589881 hasConcept C2909817843 @default.
- W2004589881 hasConcept C500558357 @default.
- W2004589881 hasConcept C57002609 @default.
- W2004589881 hasConcept C71924100 @default.
- W2004589881 hasConcept C89560881 @default.
- W2004589881 hasConceptScore W2004589881C126322002 @default.
- W2004589881 hasConceptScore W2004589881C164705383 @default.
- W2004589881 hasConceptScore W2004589881C2776336681 @default.
- W2004589881 hasConceptScore W2004589881C2777015399 @default.
- W2004589881 hasConceptScore W2004589881C2777292125 @default.
- W2004589881 hasConceptScore W2004589881C2777557582 @default.
- W2004589881 hasConceptScore W2004589881C2777565915 @default.
- W2004589881 hasConceptScore W2004589881C2777849778 @default.
- W2004589881 hasConceptScore W2004589881C2777871224 @default.
- W2004589881 hasConceptScore W2004589881C2779464278 @default.
- W2004589881 hasConceptScore W2004589881C2779581417 @default.
- W2004589881 hasConceptScore W2004589881C2780326628 @default.
- W2004589881 hasConceptScore W2004589881C2780387585 @default.
- W2004589881 hasConceptScore W2004589881C2780400711 @default.
- W2004589881 hasConceptScore W2004589881C2909817843 @default.
- W2004589881 hasConceptScore W2004589881C500558357 @default.
- W2004589881 hasConceptScore W2004589881C57002609 @default.
- W2004589881 hasConceptScore W2004589881C71924100 @default.
- W2004589881 hasConceptScore W2004589881C89560881 @default.
- W2004589881 hasIssue "08" @default.
- W2004589881 hasLocation W20045898811 @default.
- W2004589881 hasLocation W20045898812 @default.
- W2004589881 hasOpenAccess W2004589881 @default.
- W2004589881 hasPrimaryLocation W20045898811 @default.
- W2004589881 hasRelatedWork W1604564424 @default.
- W2004589881 hasRelatedWork W1983992557 @default.
- W2004589881 hasRelatedWork W2004589881 @default.
- W2004589881 hasRelatedWork W2055110016 @default.
- W2004589881 hasRelatedWork W2072845680 @default.
- W2004589881 hasRelatedWork W2086461862 @default.
- W2004589881 hasRelatedWork W2397274210 @default.
- W2004589881 hasRelatedWork W2739489729 @default.
- W2004589881 hasRelatedWork W2990458782 @default.
- W2004589881 hasRelatedWork W5919391 @default.
- W2004589881 hasVolume "100" @default.
- W2004589881 isParatext "false" @default.
- W2004589881 isRetracted "false" @default.
- W2004589881 magId "2004589881" @default.
- W2004589881 workType "article" @default.